BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gong Y, Qin S, Dai L, Tian Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct Target Ther 2021;6:396. [PMID: 34782609 DOI: 10.1038/s41392-021-00809-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu S, Niu Z, Zhang J, Ren L, Liu X, Zhang S, Zou H, Hu X, Wang J, Zhang L, Zhou Y, Song Z. Bioinformatic analysis of the S protein of human respiratory coronavirus. Mol Phylogenet Evol 2023;181:107704. [PMID: 36657625 DOI: 10.1016/j.ympev.2023.107704] [Reference Citation Analysis]
2 Newby ML, Fogarty CA, Allen JD, Butler J, Fadda E, Crispin M. Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics. J Mol Biol 2022;435:167928. [PMID: 36565991 DOI: 10.1016/j.jmb.2022.167928] [Reference Citation Analysis]
3 Chen J, Li Y, Liu Z. Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection. Cell Rep Phys Sci 2023;:101249. [PMID: 36714073 DOI: 10.1016/j.xcrp.2023.101249] [Reference Citation Analysis]
4 Cheng N, Liu M, Li W, Sun B, Liu D, Wang G, Shi J, Li L. Protein post-translational modification in SARS-CoV-2 and host interaction. Front Immunol 2022;13:1068449. [PMID: 36713387 DOI: 10.3389/fimmu.2022.1068449] [Reference Citation Analysis]
5 Bru S, González-Marrón A, Lidón-Moyano C, Carballar R, Martínez-Láinez JM, Pérez-Martín H, Fu M, Pérez-Ortuño R, Ballbè M, Pascual JA, Fernández E, Clotet J, Martínez-Sánchez JM. Determination of soluble angiotensin-converting enzyme 2 in saliva samples and its association with nicotine. Environ Res 2023;216:114443. [PMID: 36195157 DOI: 10.1016/j.envres.2022.114443] [Reference Citation Analysis]
6 Balasubramaniyam A, Ryan E, Brown D, Hamza T, Harrison W, Gan M, Sankhala RS, Chen WH, Martinez EJ, Jensen JL, Dussupt V, Mendez-Rivera L, Mayer S, King J, Michael NL, Regules J, Krebs S, Rao M, Matyas GR, Joyce MG, Batchelor AH, Gromowski GD, Dutta S. Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants. Vaccines (Basel) 2022;11. [PMID: 36679887 DOI: 10.3390/vaccines11010042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mathez G, Pillonel T, Bertelli C, Cagno V. Alpha and Omicron SARS-CoV-2 Adaptation in an Upper Respiratory Tract Model. Viruses 2022;15. [PMID: 36680054 DOI: 10.3390/v15010013] [Reference Citation Analysis]
8 Demone J, Maltseva M, Nourimand M, Nasr-Sharif M, Galipeau Y, Alarcon EI, Langlois MA, MacLean AM. Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines. PLoS One 2022;17:e0277668. [PMID: 36516116 DOI: 10.1371/journal.pone.0277668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Du W, Jiang P, Li Q, Wen H, Zheng M, Zhang J, Guo Y, Yang J, Feng W, Ye S, Kamara S, Jiang P, Chen J, Li W, Zhu S, Zhang L. Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants. Microbiol Spectr 2022. [DOI: 10.1128/spectrum.03562-22] [Reference Citation Analysis]
10 Matthews AM, Biel TG, Ortega-Rodriguez U, Falkowski VM, Bush X, Faison T, Xie H, Agarabi C, Rao VA, Ju T. SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins. PLoS One 2022;17:e0278294. [PMID: 36472974 DOI: 10.1371/journal.pone.0278294] [Reference Citation Analysis]
11 Karavanaki K, Rodolaki K, Soldatou A, Karanasios S, Kakleas K. Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management. Endocrine 2022;:1-16. [PMID: 36462147 DOI: 10.1007/s12020-022-03266-7] [Reference Citation Analysis]
12 Zhou Y, Wang H, Yang L, Wang Q. Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology. Molecules 2022;27. [PMID: 36500347 DOI: 10.3390/molecules27238257] [Reference Citation Analysis]
13 Li Y, Xu S, Ye Q, Chi H, Guo Z, Chen J, Wu M, Fan B, Li B, Qin CF, Liu Z. Rational Development of Hypervalent Glycan Shield-Binding Nanoparticles with Broad-Spectrum Inhibition against Fatal Viruses Including SARS-CoV-2 Variants. Adv Sci (Weinh) 2023;10:e2202689. [PMID: 36377484 DOI: 10.1002/advs.202202689] [Reference Citation Analysis]
14 Besson S, Laurin D, Chauvière C, Thépaut M, Kleman J, Pezet M, Manches O, Fieschi F, Aspord C, Fender P. Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses. Biomedicines 2022;10:2881. [DOI: 10.3390/biomedicines10112881] [Reference Citation Analysis]
15 Kim WS, Kim JH, Lee J, Ka SY, Chae HD, Jung I, Jung ST, Na J. Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of Escherichia coli. Bioengineering 2022;9:670. [DOI: 10.3390/bioengineering9110670] [Reference Citation Analysis]
16 Zhang Y, Sun S, Du C, Hu K, Zhang C, Liu M, Wu Q, Dong N. Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation. J Biol Chem 2022;298:102643. [PMID: 36309092 DOI: 10.1016/j.jbc.2022.102643] [Reference Citation Analysis]
17 Dehghani J, Movafeghi A, Mathieu-Rivet E, Mati-Baouche N, Calbo S, Lerouge P, Bardor M. Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants. Mar Drugs 2022;20. [PMID: 36354980 DOI: 10.3390/md20110657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chatterjee S, Zaia J. Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples. Mass Spectrom Rev 2022;:e21813. [PMID: 36177493 DOI: 10.1002/mas.21813] [Reference Citation Analysis]
19 Singh J, Vashishtha S, Rahman SA, Ehtesham NZ, Alam A, Kundu B, Dobrindt U. Energetics of Spike Protein Opening of SARS-CoV-1 and SARS-CoV-2 and Its Variants of Concern: Implications in Host Receptor Scanning and Transmission. Biochemistry 2022. [PMID: 36166360 DOI: 10.1021/acs.biochem.2c00301] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Han J, Zhu L, Zhang J, Guo L, Sun X, Huang C, Xu K, Zhang Y, Li W, Zhou Q. Rational engineering of adeno-associated virus capsid enhances human hepatocyte tropism and reduces immunogenicity. Cell Prolif 2022;:e13339. [PMID: 36135100 DOI: 10.1111/cpr.13339] [Reference Citation Analysis]
21 Safarzadeh Kozani P, Dashti Shokoohi S, Baharifar N, Sheikhi S, Khalaf Shamsabadi F, Chamaie Nejad F, Sheikhi M, Rabiee Valashedi M, Safarzadeh Kozani P, Mirarefin SMJ, Sheikhi A. ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review. Trends in Med Sci 2022;2. [DOI: 10.5812/tms-130682] [Reference Citation Analysis]
22 Tantiwiwat T, Thaiprayoon A, Siriatcharanon A, Tachaapaikoon C, Plongthongkum N, Waraho-zhmayev D. Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay. Mol Biotechnol. [DOI: 10.1007/s12033-022-00563-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Ghaemi A, Roshani Asl P, Zargaran H, Ahmadi D, Hashimi AA, Abdolalipour E, Bathaeian S, Miri SM. Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity. Front Immunol 2022;13:974364. [DOI: 10.3389/fimmu.2022.974364] [Reference Citation Analysis]
24 Masoomi Nomandan SZ, Azimzadeh Irani M, Hosseini SM. In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine. Front Mol Biosci 2022;9:976490. [DOI: 10.3389/fmolb.2022.976490] [Reference Citation Analysis]
25 Volkhina IV, Butolin EG. Clinical and Diagnostic Significance of Sialic Acids Determination in Biological Material. Biochem Moscow Suppl Ser B 2022;16:165-174. [DOI: 10.1134/s199075082203012x] [Reference Citation Analysis]
26 Wang T, Cao Y, Zhang H, Wang Z, Man CH, Yang Y, Chen L, Xu S, Yan X, Zheng Q, Wang YP. COVID-19 metabolism: Mechanisms and therapeutic targets. MedComm (2020) 2022;3:e157. [PMID: 35958432 DOI: 10.1002/mco2.157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kupai K, Várkonyi T, Török S, Gáti V, Czimmerer Z, Puskás LG, Szebeni GJ. Recent Progress in the Diagnosis and Management of Type 2 Diabetes Mellitus in the Era of COVID-19 and Single Cell Multi-Omics Technologies. Life (Basel) 2022;12:1205. [PMID: 36013384 DOI: 10.3390/life12081205] [Reference Citation Analysis]
28 Tripathi N, Goel B, Bhardwaj N, Vishwakarma RA, Jain SK. Exploring the Potential of Chemical Inhibitors for Targeting Post-translational Glycosylation of Coronavirus (SARS-CoV-2). ACS Omega. [DOI: 10.1021/acsomega.2c02345] [Reference Citation Analysis]
29 Oganesyan I, Hajduk J, Harrison JA, Marchand A, Czar MF, Zenobi R. Exploring Gas-Phase MS Methodologies for Structural Elucidation of Branched N-Glycan Isomers. Anal Chem 2022. [PMID: 35833795 DOI: 10.1021/acs.analchem.2c02019] [Reference Citation Analysis]
30 Noborn F, Nilsson J, Larson G. Site-specific glycosylation of proteoglycans: a revisited frontier in proteoglycan research. Matrix Biol 2022:S0945-053X(22)00091-9. [PMID: 35840015 DOI: 10.1016/j.matbio.2022.07.002] [Reference Citation Analysis]
31 Molnarova K, Cokrtova K, Tomnikova A, Krizek T, Kozlik P. Liquid chromatography and capillary electrophoresis in glycomic and glycoproteomic analysis. Monatsh Chem 2022;:1-28. [PMID: 35754790 DOI: 10.1007/s00706-022-02938-4] [Reference Citation Analysis]
32 Yoshida N, Maruyama Y, Mitsutake A, Kuroda A, Fujiki R, Kanemaru K, Okamoto D, Kobryn AE, Gusarov S, Nakano H. Computational Analysis of the SARS-CoV-2 RBD-ACE2-Binding Process Based on MD and the 3D-RISM Theory. J Chem Inf Model 2022. [PMID: 35583118 DOI: 10.1021/acs.jcim.2c00192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Trozzi F, Karki N, Song Z, Verma N, Kraka E, Zoltowski BD, Tao P. Allosteric control of ACE2 peptidase domain dynamics. Org Biomol Chem 2022;20:3605-18. [PMID: 35420112 DOI: 10.1039/d2ob00606e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ruocco V, Strasser R. Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana. Plants 2022;11:1093. [DOI: 10.3390/plants11081093] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Dammen-brower K, Epler P, Zhu S, Bernstein ZJ, Stabach PR, Braddock DT, Spangler JB, Yarema KJ. Strategies for Glycoengineering Therapeutic Proteins. Front Chem 2022;10:863118. [DOI: 10.3389/fchem.2022.863118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Riccio A, Santopolo S, Rossi A, Piacentini S, Rossignol JF, Santoro MG. Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence. Cell Mol Life Sci 2022;79:227. [PMID: 35391601 DOI: 10.1007/s00018-022-04246-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
37 Volkhina IV, Butolin EG. [Clinical and diagnostic significance of sialic acids determination in biological material]. Biomed Khim 2022;68:7-17. [PMID: 35221292 DOI: 10.18097/PBMC20226801007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Yin J, Li C, Ye C, Ruan Z, Liang Y, Li Y, Wu J, Luo Z. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]